A new study has found that one in three early-stage breast cancer patients who received genomic testing when deciding about treatment options felt they did not fully understand their discussions with physicians about their test results and their risk of recurrence.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Health
- Adolescent Binge Drinking Leads to Changes in Alcohol Drinking, Anxiety, and Amygdalar Corticotropin Releasing Factor Cells in A
- High school students test best with 7 hours of sleep at night
- 'Explorers,' who embrace the uncertainty of choices, use specific part of cortex
- New prenatal genetic test is much more powerful at detecting fetal abnormalities
- Research finds ways that young couples experience less relationship stress, higher satisfaction